A malignant symbiosis: The neuro-metabolic symphony rewires the tumor microenvironment

Emerging evidence in cancer neuroscience has established a reciprocal bidirectional loop between neural signaling and tumor metabolism as a central driver of malignant progression. This review critically evaluates bidirectional neuro-metabolic symbiosis and its profound implications for overcoming treatment refractoriness. We first analyzed the anterograde mechanism, in which peripheral nerve terminals and systemic endocrine factors impose distinct metabolic dependencies on malignant and stromal cell populations. By forcing alterations in nutrient utilization pathways, these neural cues create a highly immunosuppressive landscape. Conversely, we investigated the retrograde axis and established that tumor-excreted biochemicals act as potent neuromodulatory agents. Rather than functioning as mere metabolic byproducts, these molecules structurally and functionally remodel intratumoral nerve endings, lowering neuronal firing thresholds and solidifying a self-amplifying loop that drives disease aggression while triggering systemic neurological disorders in the host. Ultimately, dismantling this deleterious alliance is imperative for clinical progress. By integrating neuropharmacological interventions - such as autonomic blockade - with targeted metabolic disruption, we present a dual-pronged translational framework designed to uncouple neuro-metabolic interdependencies, thereby abrogating tumor resilience and alleviating comorbid neuropathologies.